Silvia Cabia-Pena

Villanueva De La Canada, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice.

Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice.

Journal: BMC cancer

Published: January 29, 2026

Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.

Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer.

Journal: Biomarker research

Published: January 09, 2026

Early pembrolizumab plasma levels as a prognostic biomarker in real-world NSCLC patients.

Early pembrolizumab plasma levels as a prognostic biomarker in real-world NSCLC patients.

Journal: Pharmacological research

Published: December 02, 2025

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 19, 2024

Comparison of four valproic acid free fraction determination methods used in clinical practice.

Comparison of four valproic acid free fraction determination methods used in clinical practice.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: April 05, 2022

Assessment of exposure-response relationship for cetuximab in patients with metastatic colorectal cancer and head and neck cancer.

Assessment of exposure-response relationship for cetuximab in patients with metastatic colorectal cancer and head and neck cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: April 05, 2022

Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer.

Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 06, 2021

Degree of technological implementation in intravenous chemotherapy management in hospitals of the Autonomous Community of Madrid.

Degree of technological implementation in intravenous chemotherapy management in hospitals of the Autonomous Community of Madrid.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: July 08, 2017

Population pharmacokinetics of gentamicin and dosing optimization for infants.

Population pharmacokinetics of gentamicin and dosing optimization for infants.

Journal: Antimicrobial agents and chemotherapy

Published: November 12, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026